Biden trustbusters keep new ideas on life support

Amedisys

15/11/2024 16:29

(The author is a Reuters Breakingviews columnist.  The opinions
expressed are his own.)
    By Jonathan Guilford
       NEW YORK, Nov 15 (Reuters Breakingviews) - The DOJ is
suing to stop UnitedHealth’s $3 bln deal for in-home care rival
Amedisys, arguing it would hurt patients. As with other recent
US litigation, it targets issues beyond price, in this case
quality and capacity. It’s a parting shot at codifying novel
competition theory.

    Full view will be published shortly.
    Follow @JMAGuilford on X
    
    CONTEXT NEWS
    The U.S. Department of Justice filed a lawsuit on Nov. 12 to
block healthcare conglomerate UnitedHealth’s $3.3 billion
acquisition of Amedisys, arguing that the deal would hurt
competition for in-home health and hospice services.
    Attorneys general from Maryland, Illinois, New Jersey and
New York joined in the complaint.

 (Editing by Jeffrey Goldfarb and Pranav Kiran)
 ((For previous columns by the author, Reuters customers can
click on  GUILFORD/  
Jonathan.Guilford@thomsonreuters.com))